Health

  • February 18, 2026

    FDA Changes Mind, Will Review Moderna MRNA Flu Vaccine

    Moderna on Wednesday said that the U.S. Food and Drug Administration has decided to review its application for its influenza vaccine, a week after the agency refused to consider the application for the new experimental vaccine.

  • February 18, 2026

    Neutrogena Paying $4.7M To Settle BIPA Suit Over App

    A former Johnson & Johnson subsidiary has agreed to pay $4.7 million to settle a potential class action claiming it unlawfully stored and collected facial scans of people who used its Neutrogena Skin360 tool, according to a filing in New Jersey federal court.

  • February 18, 2026

    Levi & Korsinsky To Lead Novo Nordisk Investor Class Action

    Levi & Korsinsky LLP has been appointed lead counsel in a proposed securities class action accusing Novo Nordisk A/S of misleading investors about its 2025 revenue outlook, after a New Jersey federal judge approved the firm's selection by the investor with the largest financial stake in the case.

  • February 18, 2026

    Nicotine Pouch Co. Says FDA Unfairly Applies Tobacco Regs

    A nicotine oral pouch maker is suing the U.S. Food and Drug Administration in D.C. federal court, saying the agency is arbitrarily requiring it to perform the same health studies for premarket authorization as tobacco products, despite acknowledging that its products have fewer health risks than cigarettes or other tobacco products.

  • February 18, 2026

    Pa. Providers Say They Lost Billions In Change Health Breach

    The health payment platform Change Health Inc., which was at the center of the nation's largest healthcare data breach two years ago, is facing a fresh lawsuit from a proposed class of Pennsylvania healthcare providers who claim they lost billions in payments during the breach. 

  • February 18, 2026

    Anti-Abortion Clinics Lose Free Speech Suit Over Mass. Ads

    A Massachusetts federal judge has tossed a lawsuit over a state-funded ad campaign warning consumers about potentially misleading or inaccurate information provided by a group of anti-abortion pregnancy resource centers, finding that the state hadn't prohibited the clinics from operating — and that the public officials have the same free speech rights as the clinics.

  • February 18, 2026

    Va.'s Privia Medical Group Doctor Sues In Del. For Records

    A physician member of Virginia-based Privia Medical Group LLC has sued the company in Delaware Chancery Court, accusing it of stonewalling her efforts to inspect books and records under the company's operating agreement amid concerns about insurance reimbursement practices and related risks.

  • February 18, 2026

    NextGen's $19M Data Breach Deal Gets Judge's Approval

    A Georgia federal judge gave his final sign-off to a $19 million-plus deal between NextGen Healthcare and more than a million customers whose personal information was compromised in a 2023 data breach.

  • February 17, 2026

    $500M Medical Glove Feud Must Be Arbitrated, Court Hears

    A medical gloves supplier is arguing that a Malaysian exporter must arbitrate its $500 million fraud and breach of contract suit after the two had a falling out stemming from a massive COVID-19-era pact aimed at supplying repackaged nitrile gloves to Walmart.

  • February 17, 2026

    Chancery Disallows Arbitration In No Surprises Act Cases

    In a "narrow" first impression ruling, a Delaware magistrate in Chancery has rejected claims that the federal No Surprises Act provides for a narrow private right to seek the enforcement of an arbitration award in litigation over medical bills involving the act.

  • February 17, 2026

    Judge Rips Drugmakers' Borderline 'Disingenuous' Appeal Bid

    A Connecticut federal judge has rejected generic-drug makers' request for a quick appeal of his ruling denying them summary judgment on states' claims they engaged in an "overarching conspiracy" to fix prices, slamming the request for being borderline "disingenuous," mischaracterizing his reasoning and ignoring direct evidence of alleged wrongdoing.

  • February 17, 2026

    Union Says Express Scripts Diverted Billions In Kickback Fees

    A Chicago plumbers union healthcare fund told an Illinois federal court Tuesday that the nation's largest pharmacy benefit manager, Express Scripts, violated federal criminal law when it used a Switzerland-based company to hide kickbacks it generated by charging drug companies fees for key placement on prescription plan drug lists.  

  • February 17, 2026

    Conn. Judge Says Attys 'Unprepared' At Pretrial Conference

    A Connecticut state judge on Tuesday chastised the parties in a medical malpractice case where the plaintiffs have sought more than $12 million, saying they were "completely unprepared" and "utterly ignored" a previous scheduling order.

  • February 17, 2026

    Squires Ends IPR After ITC Judge Rejects Validity Challenge

    U.S. Patent and Trademark Office Director John Squires ended a Patent Trial and Appeal Board review of a Hydrafacial LLC skin treatment patent since the same issue had already been adjudicated in the U.S. International Trade Commission.

  • February 17, 2026

    McGuireWoods Adds Sidley Private Equity Pro In Los Angeles

    McGuireWoods LLP is expanding its transactional team, announcing Tuesday that it is bringing in a Sidley Austin LLP private equity expert as a partner in its Los Angeles office.

  • February 17, 2026

    Providence Health Inks $43M Deal In 401(k) Forfeiture Suit

    Providence Health & Services has struck a nearly $43 million deal to end a suit claiming the company used forfeited cash from its retirement plan to fund its employer contributions instead of plan expenses covered by workers, an agreement that stands to benefit 200,000 class members.

  • February 17, 2026

    3 Firms Advise On $9.9B Danaher, Masimo Diagnostics Deal

    Danaher Corp. said Tuesday it has agreed to acquire Masimo Corp. in a deal valued at about $9.9 billion, including debt, with Kirkland & Ellis LLP advising Danaher and Sullivan & Cromwell LLP and White & Case LLP representing Masimo. 

  • February 17, 2026

    Ex-Federal Workers Say Reductions Were 'Political' Firings

    A group of more than 140 ex-federal employees has sued the U.S. Department of Justice and other federal agencies in Maryland federal court, challenging the Trump administration's use of "reductions in force" to make what they contend are politically motivated firings.

  • February 17, 2026

    Colo. Judge Allows Hospital To Pause Gender-Affirming Care

    A Colorado state judge declined to reinstate gender-affirming care for transgender youth patients of Children's Hospital Colorado, ruling that ordering the hospital to resume providing the care could risk the hospital's ability to provide pediatric care to other patients.

  • February 17, 2026

    Nurse, Staffing Cos. Settle 'Indentured Servitude' Suit For $1M

    Two healthcare staffing companies will pay $1 million to end a proposed class and collective action claiming they engaged in "indentured servitude" by forcing nurses to repay visa-related costs, according to an Ohio federal court filing.

  • February 17, 2026

    Edwards Sued In Chancery Over $300M Heart Valve Earn-Out

    The former shareholders of Valtech Cardio Ltd. have sued the company and its parent Edwards Lifesciences Corp. in the Delaware Chancery Court, accusing the medical device giant of deliberately stalling development of a heart valve repair system to avoid paying up to $300 million in earn-out consideration tied to the 2016 acquisition.

  • February 17, 2026

    Home Health Co. Nurses Are Employees, Judge Rules

    A home healthcare company misclassified its licensed practical nurses as independent contractors, a Pennsylvania federal judge ruled in a suit brought by the U.S. Department of Labor, saying a jury should decide how much overtime the workers are owed.

  • February 13, 2026

    RFK Jr. Taps Ex-Jones Day Atty For FDA Senior Counselor

    U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. has named a former Jones Day partner as one of the U.S. Food and Drug Administration's senior counselors, according to an announcement.

  • February 13, 2026

    States' Generic Drugs Antitrust Case Headed Toward Trial

    A Connecticut federal judge has mostly refused to side with pharmaceutical companies facing states' generic drug price-fixing litigation against them, ruling that there are genuine disputes of material fact as to drug distribution chains and the states' antitrust standing and teeing up the case for trial.

  • February 13, 2026

    Health Exec Says He Was Fired For Opposing 'Enron-Style' Plot

    Jefferson Health System terminated its former vice president of facilities management over "his refusal to participate in" what he described as "an Enron-style financial engineering scheme" related to a proposed energy-as-a-service transaction that he believed posed serious regulatory risks, according to a suit filed in Pennsylvania.

Expert Analysis

  • When Atty Ethics Violations Give Rise To Causes Of Action

    Author Photo

    Though the Model Rules of Professional Conduct make clear that a violation of the rules does not automatically create a cause of action, attorneys should beware of a few scenarios in which they could face lawsuits for ethical lapses, says Brian Faughnan at Faughnan Law.

  • What's New In FDA's Latest Cell And Gene Therapy Guidance

    Author Photo

    New draft guidance from the U.S. Food and Drug Administration, along with other recent initiatives, come together to promote cell and gene therapy product development by streamlining development and review pathways, say attorneys at Holland & Knight.

  • H-1B Fee Guidance Is Helpful But Notable Uncertainty Persists

    Author Photo

    Recent guidance narrowing the scope of the $100,000 entry fee for H-1B visas will allow employers to plan for the hiring season, but a lack of detail about the mechanics of cross-agency payment verification, fee exemptions and other practical matters still need to be addressed, say attorneys at Klasko Immigration Law Partners.

  • Risk Mitigation For Psychedelic Use In Reproductive Health

    Author Photo

    With the rising use of psychedelics among women of reproductive age and the absence of clear professional guidelines regarding risk labeling, healthcare providers and facilitators should adopt proactive, evidence-based approaches to mitigate malpractice liability risks, say Kimberly Chew at Husch Blackwell and Sara Shoar at the University of Southern California.

  • Justices' LabCorp Punt Leaves Deeper Class Cert. Circuit Split

    Author Photo

    In its ruling in LabCorp v. Davis, the U.S. Supreme Court left unresolved a standing-related class certification issue that has plagued class action jurisprudence for years — and subsequent conflicting decisions among federal circuit courts have left district courts and litigants struggling with conflicting and uncertain standards, say attorneys at Cozen O'Connor.

  • Series

    Practicing Stoicism Makes Me A Better Lawyer

    Author Photo

    Practicing Stoicism, by applying reason to ignore my emotions and govern my decisions, has enabled me to approach challenging situations in a structured way, ultimately providing advice singularly devoted to a client's interest, says John Baranello at Moses & Singer.

  • Adapting To Enforcement Focus On Wound Care Fraud

    Author Photo

    As federal agencies target wound care industry fraud as a top enforcement priority, attorneys advising industry stakeholders should evaluate business relationships for Anti-Kickback Statute violations, emphasize appropriate product use and documentation, and use internal data analytics to monitor billing patterns, say David Tarras at Tarras Defense and Jay McCormack at Verrill Dana.

  • Series

    The Biz Court Digest: Texas, One Year In

    Author Photo

    A year after the Texas Business Court's first decision, it's clear that Texas didn't just copy Delaware and instead built something uniquely its own, combining specialization with constitutional accountability and creating a model that looks forward without losing touch with the state's democratic and statutory roots, says Chris Bankler at Jackson Walker.

  • AI Product Safety Insights May Expand Foreseeability

    Author Photo

    Product liability law has long held that companies are responsible for risks they knew about or should have known about — and with AI systems now able to assess and predict hazards during the design process, companies should expect that courts will likely treat such hazards as foreseeable, says Donald Fountain at Clark Fountain.

  • AG Watch: Illinois A Key Player In State-Level Enforcement

    Author Photo

    Illinois Attorney General Kwame Raoul has systematically strengthened his office to fill federal enforcement gaps, oppose Trump administration mandates and advance state policy objectives, particularly by aggressively pursuing labor-related issues, say attorneys at Troutman.

  • Series

    Law School's Missed Lessons: Educating Your Community

    Author Photo

    Nearly two decades prosecuting scammers and elder fraud taught me that proactively educating the public about the risks they face and the rights they possess is essential to building trust within our communities, empowering otherwise vulnerable citizens and preventing wrongdoers from gaining a foothold, says Roger Handberg at GrayRobinson.

  • Organ Transplant System Reforms Mark Regulatory Overhaul

    Author Photo

    Recent oversight, enforcement and operational developments in the U.S. organ procurement and transplantation system, alongside challenges like the federal shutdown, highlight heightened regulatory scrutiny and the need for compliance to maintain public trust, say attorneys at Hall Render.

  • Federal Grantees May Soon Face More Limitations On Speech

    Author Photo

    If courts accept the administration’s new interpretation of preexisting case law, which attempts to graft onto grant recipients the existing limitations on government contractors' free speech, a more deferential standard may soon apply in determining whether an agency’s refusal or termination of a grant was in violation of the First Amendment, say attorneys at Venable.

  • 5 Crisis Lawyering Skills For An Age Of Uncertainty

    Author Photo

    As attorneys increasingly face unprecedented and pervasive situations — from prosecutions of law enforcement officials to executive orders targeting law firms — they must develop several essential competencies of effective crisis lawyering, says Ray Brescia at Albany Law School.

  • Anticipating FTC's Shift On Unfair Competition Enforcement

    Author Photo

    As the Federal Trade Commission signals that it will continue to challenge unfair or deceptive acts and practices under Section 5 of the FTC Act, but with higher evidentiary standards, attorneys counseling healthcare, technology, energy or pharmaceuticals clients should note several practice tips, says Thomas Stratmann at George Mason University.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.